PDB Short entry for 2KTU HEADER TRANSLATION 09-FEB-10 2KTU TITLE HUMAN ERF1 C-DOMAIN, "CLOSED" CONFORMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL DOMAIN, RESIDUES 276-437; COMPND 5 SYNONYM: EUKARYOTIC RELEASE FACTOR 1, ERF1, TB3-1, PROTEIN CL1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ETF1, ERF1, RF1, SUP45L1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET23B(+) KEYWDS TRANSLATION, ERF1, C DOMAIN, TERMINATION, EUKARYOTES, CYTOPLASM, KEYWDS 2 PROTEIN BIOSYNTHESIS EXPDTA SOLUTION NMR NUMMDL 24 AUTHOR A.B.MANTSYZOV,V.I.POLSHAKOV,B.BIRDSALL REVDAT 2 16-MAR-22 2KTU 1 REMARK SEQADV REVDAT 1 09-JUN-10 2KTU 0 JRNL AUTH A.B.MANTSYZOV,B.BIRDSALL,E.V.IVANOVA,E.Z.ALKALAEVA, JRNL AUTH 2 P.N.KRJUCHKOVA,G.KELLY,L.YU.FROLOVA,V.I POLSHAKOV JRNL TITL NMR ASSIGNMENTS OF THE C-TERMINAL DOMAIN OF HUMAN JRNL TITL 2 POLYPEPTIDE RELEASE FACTOR ERF1. JRNL REF BIOMOL.NMR ASSIGN. V. 1 183 2007 JRNL REFN ISSN 1874-2718 JRNL PMID 19636860 JRNL DOI 10.1007/S12104-007-9050-Z REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.B.MANTSYZOV,E.V.IVANOVA,B.BIRDSALL,P.M.KOLOSOV, REMARK 1 AUTH 2 L.L.KISSELEV,V.I.POLSHAKOV REMARK 1 TITL NMR ASSIGNMENTS OF THE C-TERMINAL DOMAIN OF HUMAN REMARK 1 TITL 2 POLYPEPTIDE RELEASE FACTOR ERF1. REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR, ARIA REMARK 3 AUTHORS : VARIAN (VNMR), BRUNGER, ADAMS, CLORE, DELANO, REMARK 3 GROS, GROSSE-KUNSTLEVE, JIANG, KUSZEWSKI, NILGES, REMARK 3 PANNU, READ, RICE, SIMONSON, WARREN (ARIA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KTU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1000101565. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 311 REMARK 210 PH : 7.0; 7.0 REMARK 210 IONIC STRENGTH : 0.08; 0.08 REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM C_ERF1_HUMAN-1, 50 MM REMARK 210 POTASSIUM CHLORIDE-2, 10 MM REMARK 210 POTASSIUM PHOSPHATE-3, 90% H2O/ REMARK 210 10% D2O; 0.8 MM [U-99% 15N] C_ REMARK 210 ERF1_HUMAN-4, 50 MM POTASSIUM REMARK 210 CHLORIDE-5, 10 MM POTASSIUM REMARK 210 PHOSPHATE-6, 90% H2O/10% D2O; REMARK 210 0.8 MM [U-99% 13C; U-99% 15N] C_ REMARK 210 ERF1_HUMAN-7, 50 MM POTASSIUM REMARK 210 CHLORIDE-8, 10 MM POTASSIUM REMARK 210 PHOSPHATE-9, 90% H2O/10% D2O; 1 REMARK 210 MM [U-99% 13C; U-99% 15N] C_ERF1_ REMARK 210 HUMAN-10, 50 MM POTASSIUM REMARK 210 CHLORIDE-11, 10 MM POTASSIUM REMARK 210 PHOSPHATE-12, 100% D2O; 0.8 MM REMARK 210 [U-99% 15N] C_ERF1_HUMAN-13, 50 REMARK 210 MM POTASSIUM CHLORIDE-14, 10 MM REMARK 210 POTASSIUM PHOSPHATE-15, 5 % REMARK 210 C12E5/HEXANOL-16, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCA; 3D HNCACB; 3D HN(CO)CA; REMARK 210 3D CBCA(CO)NH; 3D HBHA(CO)NH; 3D REMARK 210 HNCO; 3D HNHA; 3D 1H-15N NOESY; REMARK 210 3D 1H-13C NOESY; 3D HCCH-TOCSY; REMARK 210 2D DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 700 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY, NMRPIPE, TALOS, REMARK 210 ANGLESEARCH 2.10, CNS 2.1, ARIA, REMARK 210 CNSSOLVE, TOPSPIN REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 24 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-24 REMARK 465 RES C SSSEQI REMARK 465 SER A 276 REMARK 465 HIS A 441 REMARK 465 HIS A 442 REMARK 465 HIS A 443 REMARK 465 HIS A 444 REMARK 465 HIS A 445 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 338 -171.13 75.17 REMARK 500 1 PHE A 357 11.54 53.41 REMARK 500 1 THR A 358 -169.85 -106.68 REMARK 500 1 GLN A 364 -169.50 -52.66 REMARK 500 1 PHE A 406 -67.14 -148.79 REMARK 500 1 PHE A 419 170.07 58.91 REMARK 500 1 MET A 422 -168.62 -76.25 REMARK 500 1 ASP A 428 22.90 -141.27 REMARK 500 2 ASN A 325 35.05 -94.30 REMARK 500 2 THR A 338 22.29 -157.56 REMARK 500 2 PHE A 357 5.10 57.42 REMARK 500 2 THR A 362 -37.76 -133.47 REMARK 500 2 VAL A 392 -169.70 -100.47 REMARK 500 2 PHE A 406 -94.56 -124.70 REMARK 500 2 PHE A 432 -137.62 -115.40 REMARK 500 3 ASN A 325 45.19 -92.24 REMARK 500 3 THR A 338 -44.95 -20.34 REMARK 500 3 GLU A 339 42.40 -73.44 REMARK 500 3 GLN A 364 94.50 -166.81 REMARK 500 3 GLU A 365 -42.25 -159.08 REMARK 500 3 PHE A 406 -69.85 -176.45 REMARK 500 4 ASN A 325 33.35 -96.32 REMARK 500 4 ASP A 353 40.53 -91.66 REMARK 500 4 THR A 362 -36.33 -131.88 REMARK 500 4 GLN A 364 94.08 -50.04 REMARK 500 4 PHE A 406 -75.90 174.97 REMARK 500 4 ARG A 416 99.97 -60.00 REMARK 500 4 GLU A 423 -53.23 -151.61 REMARK 500 4 TYR A 424 88.61 -160.88 REMARK 500 5 ASN A 325 48.31 -91.68 REMARK 500 5 THR A 338 13.47 -163.46 REMARK 500 5 PHE A 357 15.20 49.92 REMARK 500 5 GLN A 364 166.77 -41.47 REMARK 500 5 VAL A 392 -168.03 -101.60 REMARK 500 5 PHE A 406 -77.59 -174.98 REMARK 500 5 PHE A 431 62.70 -109.12 REMARK 500 6 ASP A 327 30.31 -90.08 REMARK 500 6 THR A 362 -37.32 -131.86 REMARK 500 6 GLN A 364 90.13 -52.83 REMARK 500 6 PHE A 406 -84.72 -157.68 REMARK 500 7 ASN A 325 49.67 -97.25 REMARK 500 7 THR A 338 25.35 -168.85 REMARK 500 7 GLU A 339 38.37 -142.49 REMARK 500 7 GLN A 364 84.93 -155.59 REMARK 500 7 GLU A 365 -39.05 -144.17 REMARK 500 7 ASP A 394 5.60 -67.91 REMARK 500 7 PHE A 406 -66.01 -137.09 REMARK 500 7 PHE A 431 49.72 -101.40 REMARK 500 7 PHE A 432 89.56 -65.38 REMARK 500 8 THR A 338 -5.80 177.87 REMARK 500 REMARK 500 THIS ENTRY HAS 168 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15366 RELATED DB: BMRB REMARK 900 HUMAN ERF1 C DOMAIN REMARK 900 RELATED ID: 6763 RELATED DB: BMRB REMARK 900 HUMAN ERF1 MIDDLE DOMAIN REMARK 900 RELATED ID: 2HST RELATED DB: PDB REMARK 900 HUMAN ERF1 MIDDLE DOMAIN REMARK 900 RELATED ID: 6116 RELATED DB: BMRB REMARK 900 HUMAN ERF1 N-DOMAIN REMARK 900 RELATED ID: 1DT9 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN EUKARYOTIC RELEASE FACTOR ERF1 REMARK 900 RELATED ID: 2KTV RELATED DB: PDB REMARK 900 HUMAN ERF1 C DOMAIN DBREF 2KTU A 276 437 UNP P62495 ERF1_HUMAN 276 437 SEQADV 2KTU LEU A 438 UNP P62495 EXPRESSION TAG SEQADV 2KTU GLU A 439 UNP P62495 EXPRESSION TAG SEQADV 2KTU HIS A 440 UNP P62495 EXPRESSION TAG SEQADV 2KTU HIS A 441 UNP P62495 EXPRESSION TAG SEQADV 2KTU HIS A 442 UNP P62495 EXPRESSION TAG SEQADV 2KTU HIS A 443 UNP P62495 EXPRESSION TAG SEQADV 2KTU HIS A 444 UNP P62495 EXPRESSION TAG SEQADV 2KTU HIS A 445 UNP P62495 EXPRESSION TAG SEQRES 1 A 170 SER ASN VAL LYS PHE ILE GLN GLU LYS LYS LEU ILE GLY SEQRES 2 A 170 ARG TYR PHE ASP GLU ILE SER GLN ASP THR GLY LYS TYR SEQRES 3 A 170 CYS PHE GLY VAL GLU ASP THR LEU LYS ALA LEU GLU MET SEQRES 4 A 170 GLY ALA VAL GLU ILE LEU ILE VAL TYR GLU ASN LEU ASP SEQRES 5 A 170 ILE MET ARG TYR VAL LEU HIS CYS GLN GLY THR GLU GLU SEQRES 6 A 170 GLU LYS ILE LEU TYR LEU THR PRO GLU GLN GLU LYS ASP SEQRES 7 A 170 LYS SER HIS PHE THR ASP LYS GLU THR GLY GLN GLU HIS SEQRES 8 A 170 GLU LEU ILE GLU SER MET PRO LEU LEU GLU TRP PHE ALA SEQRES 9 A 170 ASN ASN TYR LYS LYS PHE GLY ALA THR LEU GLU ILE VAL SEQRES 10 A 170 THR ASP LYS SER GLN GLU GLY SER GLN PHE VAL LYS GLY SEQRES 11 A 170 PHE GLY GLY ILE GLY GLY ILE LEU ARG TYR ARG VAL ASP SEQRES 12 A 170 PHE GLN GLY MET GLU TYR GLN GLY GLY ASP ASP GLU PHE SEQRES 13 A 170 PHE ASP LEU ASP ASP TYR LEU GLU HIS HIS HIS HIS HIS SEQRES 14 A 170 HIS HELIX 1 1 ASN A 277 SER A 295 1 19 HELIX 2 2 GLY A 304 MET A 314 1 11 HELIX 3 3 THR A 347 ASP A 353 1 7 HELIX 4 4 PRO A 373 ASN A 381 1 9 HELIX 5 5 SER A 396 PHE A 406 1 11 HELIX 6 6 ASP A 433 HIS A 440 1 8 SHEET 1 A 4 TYR A 301 PHE A 303 0 SHEET 2 A 4 ILE A 409 LEU A 413 -1 O GLY A 411 N CYS A 302 SHEET 3 A 4 VAL A 317 TYR A 323 -1 N ILE A 321 O GLY A 410 SHEET 4 A 4 LEU A 389 VAL A 392 1 O GLU A 390 N LEU A 320 SHEET 1 B 3 LYS A 342 LEU A 346 0 SHEET 2 B 3 MET A 329 LEU A 333 -1 N LEU A 333 O LYS A 342 SHEET 3 B 3 LEU A 368 MET A 372 -1 O MET A 372 N ARG A 330 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000